COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu
Trial record 1 of 2 for:    curavac
Previous Study | Return to List | Next Study

A Study to Evaluate the Efficacy of CV-MG01 (Myasterix) in Myasthenia Gravis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03165435
Recruitment Status : Withdrawn (Not enough participating centres to complete recruitment in a timely manner.)
First Posted : May 24, 2017
Last Update Posted : May 30, 2018
University Hospital, Antwerp
Information provided by (Responsible Party):

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Estimated Primary Completion Date : October 1, 2019
Estimated Study Completion Date : December 31, 2019